Home>Topics>Stocks>Trinity Biotech PLC ADR

Trinity Biotech PLC ADR

  1. All
  2. Commentary
  3. Headlines
  1. OraSure Seems Too Cheap Relative To Infectious Disease Opportunities

    Headlines

    Thu, 6 Mar 2014

    By Stephen Simpson, CFA : Investors can be a fickle bunch. While they will happily reward strong growth stories with eye-popping valuation multiples, they can be demanding when it comes to the timing of that growth and the marketing/investment spending that the company has to do to generate it. ...

  2. Trinity Biotech's CEO Discusses Q4 2013 Results - Earnings Call Transcript

    Headlines

    Tue, 4 Mar 2014

    Trinity Biotech plc ( TRIB ) Q4 2013 Earnings Conference Call March 04, 2014 11:00 AM ET Executives Joe Diaz – Managing Partner-Lytham Partners LLC Kevin Tansley – Chief

  3. From Barron’s, July 22, 2013 (Part 2)

    Commentary

    Sat, 20 Jul 2013

    150; pg 20]; global energy producer Hess [ HES ; pg 22]; medical testing equipment/instrument maker Trinity Biotech [ TRIB ; for diabetes at $25,000/device, Lyme disease, autoimmune disorders, herpes, syphilis, strep pneumonia, cardiac evaluation

  4. From Barron’s, October 1, 2012 (Part 2)

    Commentary

    Sat, 29 Sep 2012

    spinoff from Kraft ( KFT ) whose new ticker will be KRFT ; pg 16); diabetes and other testing equipment maker Trinity Biotech ( TRIB ; pg 19); Steelcase ( SCS ; pg 20; see link below). SCS story http://online.barrons.com/article/SB50001424053111904414004578016383267957450

Content Partners